| 网站首页 | 眼科中心 | 协和眼科 | 会议中心 | 医学资源 | 精美图片 | 论坛 | 会员中心 | 帮助中心 | 换眼科点 | 申请权限 | 全站搜索 | 博客 | 手术视频 | 眼科淘宝 | 
最新公告:

  没有公告

您现在的位置: 心灵之窗-眼科医生网 >> 会议中心 >> 第11届全国会 >> 眼底病11 >> 正文
专题栏目
更多内容
相关文章
更多内容
Photodynamic therapy of subfoveal choroidal neovascularisation in Taiwanese patients with pathologic myopia: a 2-year follow-up         
Photodynamic therapy of subfoveal choroidal neovascularisation in Taiwanese patients with pathologic myopia: a 2-year follow-up
作者:Ying-Sha… 文章来源:1 Department of Ophthalmology, Cathay General Hospital, Hsinchu, Taiwan 2 Department of Ophthalmology, Taipei Medical University-Wan Fang Hospital, 点击数:6708 更新时间:2006/7/11 22:57:20
Purpose: To examine the efficacy of photodynamic therapy (PDT) with verteporfin (VPDT) in the treatment of subfoveal choroidal neovascularisation (CNV) in patients with pathologic myopia (>-8.00 dioptres). Methods: Prospective study of adult patients (≥ 18 years) with subfoveal CNV; treated in two tertiary referral centres with standard protocol of VPDT. Best-corrected visual acuity (VA) was measured at baseline and at 1, 3, 6, 12, 15, 18, and 24 months after VPDT. Stratified analyses for those with single and multiple treatments, and different age groups were performed by paired t-tests against baseline. Results: Thirty-three patients with one VPDT treatment and 13 patients with multiple treatments were enrolled for the analysis. Mean VA continued to improve over the study period; statistically significant improvement in measurement of VA was found after one month of follow-up for group with single therapy. For group with multiple treatments, trends was not as clear. In risk factor analysis by age, younger group had better mean VA compared with older group at end of the 24-month study period. Trend of improvement is also much more evident in the younger group. Conclusion: In Taiwanese patients showing response to single VPDT, VA significantly improved and continued to improve over 2-year study period. In patients who received multiple treatments, trend was not as distinctive, suggesting alternative treatment options in this subgroup of patients.
会议投稿录入:毛进    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2012
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备12035550号